Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR8K5 Inhibitors

Understanding the regulation and expression of the hypothetical protein OR8K5 is a fascinating area of study within molecular biology, focusing on the intricate mechanisms that control gene activity. OR8K5, like many genes, can be subject to regulation at various levels, including transcriptional, post-transcriptional, and translational stages. The expression of OR8K5 can be influenced by changes in the cellular environment, which can be induced by various chemical compounds. These compounds can interact directly with the DNA, RNA, or associated histones, potentially leading to a decrease in the production of OR8K5. For example, chemicals that alter the epigenetic state of DNA-such as histone deacetylase inhibitors or DNA methyltransferase inhibitors-can change how tightly DNA is wound around histones, thus affecting the accessibility of the DNA for transcription and ultimately leading to reduced gene expression. Several compounds have been identified that could downregulate the expression of OR8K5 by interfering with these fundamental biological processes. Compounds like Trichostatin A and Vorinostat are known to inhibit histone deacetylases, potentially tightening the chromatin structure and decreasing transcriptional activity at the OR8K5 locus. On the other hand, agents such as 5-Azacytidine and Decitabine can reduce DNA methylation, which might conversely lead to transcriptional repression depending on the context of other regulatory elements and transcription factor bindings. Additionally, transcription inhibitors like Actinomycin D bind directly to DNA and prevent the transcription machinery from accessing the gene, thereby reducing mRNA synthesis. Moreover, translation process inhibitors such as Puromycin disrupt the protein synthesis machinery, leading to the production of incomplete, non-functional protein chains, effectively decreasing the overall levels of functional OR8K5 protein. Each of these chemicals plays a role in the complicated network of cellular processes that determine the expression level of genes like OR8K5, providing valuable insights into the molecular control mechanisms that govern cellular function.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A, a histone deacetylase inhibitor, can remodel chromatin to a more closed state, thereby reducing the transcriptional activity of genes including OR8K5.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferases, 5-Azacytidine can decrease methylation levels on the OR8K5 gene promoter, leading to a reduction in its transcription.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG 108 specifically targets and inhibits DNA methyltransferases, causing a decrease in the methylation of the OR8K5 gene, which can lead to its transcriptional downregulation.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid disrupts gene expression by inhibiting histone deacetylases, potentially leading to the compacting of chromatin around the OR8K5 gene and decreasing its transcription.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds selectively to DNA, inhibiting the binding of transcription factors to the promoter region of OR8K5, which results in decreased mRNA synthesis.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine disrupts endosomal and lysosomal acidification, which can lead to a decrease in the cellular processing and degradation systems, indirectly leading to reduced expression of OR8K5.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA transcription initiation complexes, blocking RNA polymerase action and thereby decreasing the transcription of the OR8K5 gene.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine causes hypomethylation of the OR8K5 gene promoter by inhibiting DNA methyltransferases, leading to transcriptional silencing of this gene.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram interrupts the binding of essential transcription factors to DNA, leading to a decrease in the transcriptional initiation of the OR8K5 gene.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid binds to its specific receptors, which may bind to the promoter regions of target genes like OR8K5, leading to the repression of its transcription.